Literature DB >> 1914496

Binding sites for human interleukin 1 alpha, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus.

E J Fabre1, J Bureau, Y Pouliquen, G Lorans.   

Abstract

Keratoconus, a bilateral corneal disease, is characterized by modifications in corneal shape and thinning of the stroma. From a biochemical point of view, a decrease in collagen content, probably due to the high collagenase activity, has been reported. Gamma Interferon (gamma-IFN), Tumor Necrosis Factor (TNF), and Interleukin 1 (IL1) are peptide regulatory factors involved in immunological responses, but they also play a role in the synthesis of collagen and prostaglandin E2 by fibroblasts. In these experiments, we have determined the number of membrane binding sites for gamma-IFN, TNF, and IL1, and the dissociation constant (Kd) for each radiolabelled ligand. All experiments were carried out on cultured corneal stromal cells. Data from normal human corneas and from keratoconus were compared. No differences were found concerning gamma-IFN and TNF binding sites between normal corneas and keratoconus, while fibroblasts from keratoconus proved to bear four fold more IL1 binding sites than normal fibroblasts, with similar Kd.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914496     DOI: 10.3109/02713689109013850

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  15 in total

Review 1.  Keratoconus: an inflammatory disorder?

Authors:  V Galvis; T Sherwin; A Tello; J Merayo; R Barrera; A Acera
Journal:  Eye (Lond)       Date:  2015-05-01       Impact factor: 3.775

2.  Quercetin modulates keratoconus metabolism in vitro.

Authors:  Tina B McKay; Akhee Sarker-Nag; Desiree' Lyon; John M Asara; Dimitrios Karamichos
Journal:  Cell Biochem Funct       Date:  2015-07-14       Impact factor: 3.685

3.  Explorative study of interleukin levels in the human cornea.

Authors:  J Becker; S Salla; U Dohmen; C Redbrake; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

4.  Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.

Authors:  Ying-Ting Chen; Stanislav Lazarev; Ahmad F Bahrami; Lisa B Noble; Feeling Y T Chen; Delu Zhou; Marianne Gallup; Mahesh Yadav; Nancy A McNamara
Journal:  Lab Invest       Date:  2012-01-09       Impact factor: 5.662

5.  Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.

Authors:  Francisco Amparo; Mohammad H Dastjerdi; Andre Okanobo; Giulio Ferrari; Leila Smaga; Pedram Hamrah; Ula Jurkunas; Debra A Schaumberg; Reza Dana
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

6.  Acute keratoconus induced by hypothyroxinemia during pregnancy.

Authors:  Z Gatzioufas; S Thanos
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

7.  Anti-inflammatory effects of hinokitiol on human corneal epithelial cells: an in vitro study.

Authors:  J Ye; Y-F Xu; L-X Lou; K Jin; Q Miao; X Ye; Y Xi
Journal:  Eye (Lond)       Date:  2015-05-08       Impact factor: 3.775

8.  Subnormal cytokine profile in the tear fluid of keratoconus patients.

Authors:  Albert S Jun; Leslie Cope; Caroline Speck; Xiaojun Feng; Seakwoo Lee; Huan Meng; Abdel Hamad; Shukti Chakravarti
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

9.  Tear proteomics in keratoconus.

Authors:  Catherine Pannebaker; Heather L Chandler; Jason J Nichols
Journal:  Mol Vis       Date:  2010-10-02       Impact factor: 2.367

10.  Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients.

Authors:  So-Hee Kim; Jee-Won Mok; Hyun-Seok Kim; C K Joo
Journal:  Mol Vis       Date:  2008-11-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.